Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluation of the Efficacy of rhBNP in Patients With Diuretic Resistance After Cardiac Surgery
Sponsor: The First Affiliated Hospital of Anhui Medical University
Summary
evaluation of the efficacy of recombinant human brain natriuretic peptide in patients with diuretic resistance after cardiac surgery: a prospective single-center single-blind randomized controlled study
Official title: Evaluation of the Efficacy of Recombinant Human Brain Natriuretic Peptide in Patients With Diuretic Resistance After Cardiac Surgery: a Prospective Single-center Single-blind Randomized Controlled Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2025-08-01
Completion Date
2028-06-30
Last Updated
2025-07-25
Healthy Volunteers
No
Conditions
Interventions
rhBNP and standard basic treatment
After administering a bolus of rhBNP at 1.5-2 μg/kg intravenously, a maintenance dose of 0.0075-0.01 μg/kg/min is continuously infused intravenously for 72 hours, with the dosage adjusted based on blood pressure and heart rate; the control group receives standard basic treatment.
Locations (1)
the First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China